drug

Lovaza

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Massachusetts General Hospital
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
NCT00833976Phase 4Completed

KOLs & investigators

1
Marlene P Freeman, MD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Massachusetts General Hospital
company
trial
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
PHASE4
trial
indication
Schizophrenia
indication
Hypercholesterolemia
indication
Hypertriglyceridemia
indication
Bipolar Disorder
indication
KOL
Marlene P Freeman, MD
KOL score —
person